IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,926 | -52.5% | 24,819 | -26.6% | 0.00% | -100.0% |
| Q2 2023 | $237,952 | +48.1% | 33,800 | +28.5% | 0.00% | -50.0% |
| Q1 2023 | $160,687 | +0.4% | 26,299 | +81.8% | 0.00% | -50.0% |
| Q2 2022 | $160,000 | -95.0% | 14,467 | -92.4% | 0.00% | -95.3% |
| Q1 2022 | $3,190,000 | -29.2% | 191,593 | -18.9% | 0.08% | -39.3% |
| Q4 2021 | $4,508,000 | +922.2% | 236,146 | +1596.2% | 0.14% | +438.5% |
| Q1 2021 | $441,000 | – | 13,922 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |